Its promising, and in 10 years we might say, Hey, this stuff is great, what youre giving is pure and safe. But right now, its just so unregulated that we just dont know what these things really do in the human body, Spittler said
Do not rub the injection site, as this can alter absorption and cause irritation
Phase III clinical data from SCENESSE trials (the FDA-approved formulation of afamelanotide) demonstrated that patients with erythropoietic protoporphyria achieved clinically meaningful photoprotection after 60 days of sustained drug delivery via controlled-release implant
Add social media, podcasts and the growing interest in longevity and performance medicine, and youve got the perfect environment for something like BPC-157 to explode in popularity. Recovery, it seems, has become the new performance metric